Cargando…
Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants—study protocol for the AZTEC-FU study
BACKGROUND: Preterm birth, especially at less than 30 weeks’ gestation, is significantly associated with respiratory, neurodevelopmental and growth abnormalities. The AZTEC study has recruited 799 infants born at < 30 weeks’ gestation to determine if a ten-day intravenous treatment with azithromy...
Autores principales: | Kotecha, Sarah J., Course, Christopher W., Jones, Kathryn E., Watkins, W. John, Berrington, Janet, Gillespie, David, Kotecha, Sailesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490707/ https://www.ncbi.nlm.nih.gov/pubmed/36131325 http://dx.doi.org/10.1186/s13063-022-06730-x |
Ejemplares similares
-
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants
por: Lowe, John, et al.
Publicado: (2020) -
AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
por: Lau, Tin Man Mandy, et al.
Publicado: (2022) -
All-Cause Mortality of Low Birthweight Infants in Infancy, Childhood, and Adolescence: Population Study of England and Wales
por: Watkins, W. John, et al.
Publicado: (2016) -
Fractional exhaled nitric oxide in preterm‐born subjects: A systematic review and meta‐analysis
por: Course, Christopher W., et al.
Publicado: (2019) -
Association of Gestation and Fetal Growth Restriction on Cardiovascular Health in Preterm-Born Children
por: Course, Christopher W., et al.
Publicado: (2023)